Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1985The Journal of Clinical Endocrinology & Metabolism

RU486, A Progestin and Glucocorticoid Antagonist, Inhibits the Growth of Breast Cancer Cells via the Progesterone Receptor*

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSylvie BardonInstitut National de la Recherche AgronomiqueFVFRANCHISE VIGKPNDCDany ChalbosInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bardon et al. (1985) studied this question.

synapsesocial.com/papers/6a71e569c92390ac2d0806c0https://doi.org/10.1210/jcem-60-4-692
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells.1984 · 76 citations
  2. 2Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation1978 · 296 citations